Published in J Biol Chem on August 04, 2000
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor. J Biol Chem (2005) 1.54
Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep (2007) 1.47
A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor. J Med Chem (2004) 1.35
Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Sci (2006) 1.15
Molecular cloning and characterization of a nuclear androgen receptor activated by 11-ketotestosterone. Reprod Biol Endocrinol (2005) 1.06
A critical role of helix 3-helix 5 interaction in steroid hormone receptor function. Proc Natl Acad Sci U S A (2005) 1.00
Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. Br J Pharmacol (2003) 0.99
Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design. J Biol Chem (2007) 0.96
Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H. J Biol Chem (2009) 0.88
Androgen receptor gene mutation, rearrangement, polymorphism. Transl Androl Urol (2013) 0.87
Interaction of organophosphate pesticides and related compounds with the androgen receptor. Environ Health Perspect (2003) 0.83
Spongian diterpenoids inhibit androgen receptor activity. Mol Cancer Ther (2013) 0.82
Targeting the androgen receptor with steroid conjugates. J Med Chem (2014) 0.79
Helix 3-helix 5 interactions in steroid hormone receptor function. J Steroid Biochem Mol Biol (2008) 0.78
Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer. World J Urol (2011) 0.78
Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain. J Biol Chem (2016) 0.77
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98
Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90
Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature (1990) 9.21
An attempt to unify the structure of polymerases. Protein Eng (1990) 7.93
Chemical and biological evolution of nucleotide-binding protein. Nature (1974) 7.39
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 6.82
Crystallographic refinement of yeast aspartic acid transfer RNA. J Mol Biol (1985) 6.33
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Class II aminoacyl transfer RNA synthetases: crystal structure of yeast aspartyl-tRNA synthetase complexed with tRNA(Asp). Science (1991) 4.87
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (1995) 4.79
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 4.69
Correlation between segmental mobility and the location of antigenic determinants in proteins. Nature (1984) 3.66
Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell (1998) 3.27
The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol (1994) 3.16
Zinc ion mediated amino acid discrimination by threonyl-tRNA synthetase. Nat Struct Biol (2000) 2.97
The bromodomain revisited. Trends Biochem Sci (1997) 2.95
An operational RNA code for amino acids and possible relationship to genetic code. Proc Natl Acad Sci U S A (1993) 2.87
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell (2000) 2.77
The structure of threonyl-tRNA synthetase-tRNA(Thr) complex enlightens its repressor activity and reveals an essential zinc ion in the active site. Cell (1999) 2.74
Crystal structure of yeast tRNAAsp. Nature (1980) 2.61
Yeast tRNA(Asp) recognition by its cognate class II aminoacyl-tRNA synthetase. Nature (1993) 2.57
Spontaneous assembly of double-stranded helicates from oligobipyridine ligands and copper(I) cations: structure of an inorganic double helix. Proc Natl Acad Sci U S A (1987) 2.57
Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. Proteins (2004) 2.51
Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology (1984) 2.48
Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol (1999) 2.40
Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell (2000) 2.33
Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol (2001) 2.25
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol (1991) 2.23
Structural and functional considerations of the aminoacylation reaction. Trends Biochem Sci (1997) 2.22
Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 2.22
The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol (1994) 2.20
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol (1989) 2.13
Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RNA crystals. Acta Crystallogr A (1988) 2.08
Homo-FRET microscopy in living cells to measure monomer-dimer transition of GFP-tagged proteins. Biophys J (2001) 2.07
Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II solution to the double discrimination problem. Cell (2000) 2.05
Studies of asymmetry in the three-dimensional structure of lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1975) 2.05
A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell (2001) 2.02
The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. EMBO J (1994) 1.99
Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol (2001) 1.97
Monoclonal antibodies against respiratory syncytial virus and their use for rapid detection of virus in nasopharyngeal secretions. J Clin Microbiol (1985) 1.96
tRNA aminoacylation by arginyl-tRNA synthetase: induced conformations during substrates binding. EMBO J (2000) 1.88
Synthesis of aspartyl-tRNA(Asp) in Escherichia coli--a snapshot of the second step. EMBO J (1999) 1.88
Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J (2000) 1.86
Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol (2001) 1.82
Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. J Steroid Biochem (1984) 1.76
Isolation of a human pararotavirus. Virology (1983) 1.73
Quantification of enterovirus RNA in sludge samples using single tube real-time RT-PCR. Biotechniques (2000) 1.67
Identification of Epstein-Barr virus sequences that encode a nuclear antigen expressed in latently infected lymphocytes. Proc Natl Acad Sci U S A (1984) 1.66
The aminoacyl-tRNA synthetase family: modules at work. Bioessays (1993) 1.64
D-glyceraldehyde-3-phosphate dehydrogenase: three-dimensional structure and evolutionary significance. Proc Natl Acad Sci U S A (1973) 1.64
The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol (1981) 1.64
Molecular structure of human TFIIH. Cell (2000) 1.64
Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family. Cell (1998) 1.63
Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector. J Virol (1987) 1.61
Nucleotide sequence of SHV-2 beta-lactamase gene. Antimicrob Agents Chemother (1990) 1.61
Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol (2000) 1.60
Crystal structure of Aeromonas proteolytica aminopeptidase: a prototypical member of the co-catalytic zinc enzyme family. Structure (1994) 1.58
Structure determination of crystalline lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol (1974) 1.57
Structural studies on nuclear receptors. Cell Mol Life Sci (2000) 1.57
Daunorubicin in the treatment of acute myelocytic leukaemia. Lancet (1969) 1.56
Novel NADPH-binding domain revealed by the crystal structure of aldose reductase. Nature (1992) 1.54
Crystallographic structure of an RNA helix: [U(UA)6A]2. J Mol Biol (1989) 1.53
Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Res (1991) 1.53
Molecular prenatal diagnosis of partial androgen insensitivity syndrome based on the Hind III polymorphism of the androgen receptor gene. Clin Endocrinol (Oxf) (1994) 1.51
Crystal structure of glycyl-tRNA synthetase from Thermus thermophilus. EMBO J (1995) 1.50
Comparison of the tertiary structure of yeast tRNA(Asp) and tRNA(Phe) in solution. Chemical modification study of the bases. J Mol Biol (1987) 1.50
Solution structure of a tRNA with a large variable region: yeast tRNASer. J Mol Biol (1989) 1.47
TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ (2008) 1.47
Binding of ligands and activation of transcription by nuclear receptors. Annu Rev Biophys Biomol Struct (2001) 1.46
Molecular prenatal exclusion of familial partial androgen insensitivity (Reifenstein syndrome) Eur J Endocrinol (1994) 1.46
The human TFIID components TAF(II)135 and TAF(II)20 and the yeast SAGA components ADA1 and TAF(II)68 heterodimerize to form histone-like pairs. Mol Cell Biol (2000) 1.45
[Polycystic ovary syndrome in pubertal period: clinical, biological, metabolic and genetic polymorphism]. Gynecol Obstet Fertil (2004) 1.43
Base-pairing shift in the major groove of (CA)n tracts by B-DNA crystal structures. Nature (1991) 1.42
Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center. J Biol Chem (2000) 1.42
Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP. EMBO J (1997) 1.41
The 2.0 A crystal structure of Thermus thermophilus methionyl-tRNA synthetase reveals two RNA-binding modules. Structure (2000) 1.40
Dynamics of ovarian function in an adult woman with McCune--Albright syndrome. J Clin Endocrinol Metab (2001) 1.39
[Preimplantation diagnosis of delta F508 mutation of mucoviscidosis in transgenic mice]. Presse Med (1995) 1.38
Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. J Biol Chem (1991) 1.37
Crystal structure of histidyl-tRNA synthetase from Escherichia coli complexed with histidyl-adenylate. EMBO J (1995) 1.35
The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution. Structure (1997) 1.34
Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol (2001) 1.33
L-arginine recognition by yeast arginyl-tRNA synthetase. EMBO J (1998) 1.33
3-D graphics modelling of the tRNA-like 3'-end of turnip yellow mosaic virus RNA: structural and functional implications. J Biomol Struct Dyn (1987) 1.33
The TBP-like factor: an alternative transcription factor in metazoa? Trends Biochem Sci (1999) 1.33
Crystal structure of aspartyl-tRNA synthetase from Pyrococcus kodakaraensis KOD: archaeon specificity and catalytic mechanism of adenylate formation. EMBO J (1998) 1.31
Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett (1998) 1.31
A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J (1997) 1.30
Conformational adaptation of agonists to the human nuclear receptor RAR gamma. Nat Struct Biol (1998) 1.29
The structure of an AspRS-tRNA(Asp) complex reveals a tRNA-dependent control mechanism. EMBO J (2001) 1.28
X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J (2001) 1.27
Recognition of tRNAs by aminoacyl-tRNA synthetases. FASEB J (1993) 1.27